A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.7, 2003-01, pp. : 473-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatment of Depression in HIV-Positive Patients: Safety Considerations

By Pieper Andrew A.

Drug Safety, Vol. 28, Iss. 9, 2005-01 ,pp. : 753-762

Adis International

Access to resources Recommend Favorite

Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients: An Updated Review

By Watkins Crystal C.

Drug Safety, Vol. 34, Iss. 8, 2011-08 ,pp. : 623-639

Adis International

Access to resources Recommend Favorite

Potential benefits of carnitine in HIV-positive patients

By Rezaee Haleh Khalili Hossein Salamzadeh Jamshid Jafari Sirus Abdollahi Alireza

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 73-83

Future Medicine

Access to resources Recommend Favorite

HIV-positive injection drug users incur high hospital costs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 335, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Relationships Between Exposure to Saquinavir Monotherapy and Antiviral Response in HIV-Positive Patients

By Gieschke R. Fotteler B. Buss N. Steimer J-L.

Clinical Pharmacokinetics, Vol. 37, Iss. 1, 1999-07 ,pp. : 75-86

Adis International

Access to resources Recommend Favorite